Back
Eli Lilly & Co. Vs. Structure Therapeutics, Inc. Sector Stock Comparison
Buy
84
LLY
Eli Lilly & Co.
Last Price:
$1,076.82
Seasonality Move:
3.95%
Buy
63
GPCR
Structure Therapeutics, Inc.
Last Price:
$69.61
Seasonality Move:
-34.19%
Buy
84
Eli Lilly & Co. (LLY)
is a Buy
Is Eli Lilly & Co. a Buy, Sell or Hold?
-
The current Eli Lilly & Co. [LLY] share price is $1,076.98. The Score for LLY is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
-
LLY is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
63
Structure Therapeutics, Inc. (GPCR)
is a Buy
Is Structure Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Structure Therapeutics, Inc. [GPCR] share price is $69.69. The Score for GPCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LLY Stock Price Chart
What is Eli Lilly & Co.'s stock price today?
-
The Eli Lilly & Co. share price today is $1,076.98Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LLY is experiencing slight selling pressure.
GPCR Stock Price Chart
What is Structure Therapeutics, Inc.'s stock price today?
-
The Structure Therapeutics, Inc. share price today is $69.69Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing slight selling pressure.
LLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 24.52 | Buy |
| Relative Strength Index (14 RSI): | 64.19 | Buy |
| Chaikin Money Flow: | -320965 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1015.55 - 1080.21) | Buy |
| Bollinger Bands (100): | (719.2 - 996.84) | Buy |
GPCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.55 | Buy |
| Relative Strength Index (14 RSI): | 70.17 | Buy |
| Chaikin Money Flow: | -284110 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.64 - 66.86) | Buy |
| Bollinger Bands (100): | (17.09 - 46.21) | Buy |
LLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1063.96 | Buy |
| 20-day SMA: | 1043.21 | Buy |
| 50-day SMA: | 970.89 | Buy |
| 200-day SMA: | 821.52 | Buy |
| 8-day EMA: | 1061.64 | Buy |
| 20-day EMA: | 1041.42 | Buy |
| 50-day EMA: | 980.25 | Buy |
| 200-day EMA: | 858.86 | Buy |
GPCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.76 | Buy |
| 20-day SMA: | 54.7 | Buy |
| 50-day SMA: | 41.07 | Buy |
| 200-day SMA: | 26.34 | Buy |
| 8-day EMA: | 65.27 | Buy |
| 20-day EMA: | 57.2 | Buy |
| 50-day EMA: | 45.22 | Buy |
| 200-day EMA: | 31.64 | Buy |
Eli Lilly & Co. Earnings Growth & LLY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $10.82 per share, and an increase next year of $8.90 per share.
Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.10 per share.
Eli Lilly & Co. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Structure Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||